Sign in
CompletedPhase 2/3

Biofreeze and the Effect on Knee Osteoarthritis

Key facts

Who runs it
Memorial University of Newfoundland
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 2/3
People taking part
70 people enrolled
Started
1 Nov 2020
Ended
1 Jan 2024
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Biofreeze 4 % Topical Gel
  • Biofreeze placebo gel
Record updated
4 December 2024

Who can take part

Age
50 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Men and women aged 50-80 years
  • Body mass index (BMI) less than 40
  • Knee osteoarthritis of grade one or more according to Kellgren-Lawrence scale
  • Average pain intensity of grade 4 or more on a 10-point visual analogue scale for at least 6 months
  • Meet clinical and radiographic criteria of the American College of Rheumatology (ACR) for knee OA

Who cannot take part

  • Patients receiving multiple corticosteroid injections (Greater than 2 injections)
  • Rheumatologic diseases
  • History of knee replacement surgery
  • Acute arthritis,
  • Infective arthritis
  • Traumatic arthritis,

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Knee osteoarthritis (OA) is a progressive disease that can be accompanied by considerable joint pain and dysfunction. It is a goal in the medical field to find effective treatments for knee OA that are non-interventional, have minor or no negative side effects, and are relatively easy to administer for the patient and health care professionals. Biofreeze, a topical analgesic containing menthol, is an easily accessible gel, with no known serious negative side effects. If the application of Biofreeze can reduce the pain and dysfunction associated with knee OA, it could be an effective treatment for patients. The objective of the study is to assess how 4 weeks of Biofreeze application to a knee affected by OA effects pain and dysfunction associated with the disease.

The 2 groups in the trial

  • Topical analgesia (+Menthol)Treatment being tested

    Biofreeze Topical Gel with active ingredient (Menthol 4%)

    Treatment: Biofreeze 4 % Topical Gel

  • Topical analgesia (-Menthol)Placebo, for comparison

    Biofreeze Topical Gel with no active ingredient (Menthol 0%)

    Treatment: Biofreeze placebo gel

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of a Menthol Gel (Biofreeze) on the Symptoms Associated with Knee Osteoarthritis: a Double-blind Randomized Control Trial.
Record updated
4 December 2024